Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia

CompletedOBSERVATIONAL
Enrollment

171

Participants

Timeline

Start Date

September 23, 2015

Primary Completion Date

December 12, 2016

Study Completion Date

December 12, 2016

Conditions
Non-Interventional Study
Interventions
OTHER

Overall satisfaction questionnaires of home use of Nivestim

Trial Locations (28)

10117

Campus Charite Mitte, Med. Klinik m. Schwerpunkt Haematologie und Onkologie, Berlin

13055

Office of Reinhard Musch, Berlin

13595

Office of Peter Klare, Berlin

18435

Office of Carsten Hielscher, Stralsund

26121

Office of Burkhard Otremba, Oldenburg

30449

Office of Peter von Wussow, Hanover

44623

Office of Lars-Jörgen Hahn, Herne

44787

Office of Ute Bückner, Bochum

45879

Office of Ivo Azeh, Gelsenkirchen

47804

Office of Michael Neise, Krefeld

47805

Office of Gunther Rogmans, Krefeld

48149

Office of Christian Lerchenmüller, Münster

49076

Office of Julian Topaly, Osnabrück

52222

Office of Matthias Groschek, Stolberg

63110

Office of Andre-Robert Rotmann, Rodgau

63739

Office of Manfred Welslau, Aschaffenburg

Office of Martine Klausmann, Aschaffenburg

65191

Office of Ortwin Klein, Wiesbaden

68165

Office of Udo Hieber, Mannheim

70193

Office of Thomas Kuhn, Stuttgart

80638

Office of Christoph Salat, München

86150

Office of Bernhard Heinrich, Augsburg

89518

Office of Volker Petersen, Heidenheim

96317

Office of Peter Anhut, Kronach

09117

Office of Peter Jungberg, Chemnitz

04103

Office of Albrecht Kretzschmar, Leipzig

04107

Office of Nidal Gazawi, Leipzig

09481

Office of Rene Schubert, Scheibenberg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY